You are cordially invited by your Bristol Myers Squibb representative to attend a presentation that will focus on: A clinical discussion on a first-line treatment option for ESA naive patients with lower-risk-myelodysplastic syndrome-associated anemia: Patient Management with Hypothetical Patient Cases.